Gemcitabine-Based Chemoradiotherapy Enhanced by a PARP Inhibitor in Pancreatic Cancer Cell Lines

por Waissi, Waisse, Amé, Jean-Christophe, Mura, Carole, Noël, Georges, Burckel, Hélène
Publicado en Int J Mol Sci (2021)

Radiosensitizing Pancreatic Cancer with PARP Inhibitor and Gemcitabine: An In Vivo and a Whole-Transcriptome Analysis after Proton or Photon Irradiation

por Waissi, Waisse, Nicol, Anaïs, Jung, Matthieu, Rousseau, Marc, Jarnet, Delphine, Noel, Georges, Burckel, Hélène
Publicado en Cancers (Basel) (2021)

Poly-(ADP-ribose)-polymerase inhibitors as radiosensitizers: a systematic review of pre-clinical and clinical human studies

por Lesueur, Paul, Chevalier, François, Austry, Jean-Baptiste, Waissi, Waisse, Burckel, Hélène, Noël, Georges, Habrand, Jean-Louis, Saintigny, Yannick, Joly, Florence
Publicado en Oncotarget (2017)